UBS ASSET MANAGEMENT AMERICAS LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,404,217
+57.0%
34,400
+38.5%
0.00%0.0%
Q2 2023$1,531,8220.0%24,8350.0%0.00%0.0%
Q1 2023$1,531,822
-26.3%
24,835
-7.9%
0.00%0.0%
Q4 2022$2,078,961
-99.8%
26,954
+7.8%
0.00%0.0%
Q3 2022$1,115,634,000
+32.0%
25,003
+13.3%
0.00%
Q2 2022$845,167,000
-11.1%
22,067
-3.9%
0.00%
Q1 2022$950,273,000
+9.6%
22,9590.0%0.00%
Q4 2021$867,392,000
+14.6%
22,9590.0%0.00%
Q3 2021$756,729,000
-59.4%
22,959
-16.9%
0.00%
-100.0%
Q2 2021$1,863,582,000
+32.5%
27,625
+11.2%
0.00%0.0%
Q1 2021$1,406,837,000
-36.1%
24,847
-8.1%
0.00%0.0%
Q4 2020$2,203,194,000
+11.7%
27,043
-2.3%
0.00%0.0%
Q3 2020$1,971,701,000
-11.7%
27,673
+2.0%
0.00%0.0%
Q2 2020$2,232,092,000
+105.2%
27,128
+46.7%
0.00%0.0%
Q1 2020$1,087,943,000
-54.8%
18,493
-20.7%
0.00%0.0%
Q4 2019$2,409,115,000
+798.7%
23,308
+76.0%
0.00%
Q3 2019$268,058,000
-55.2%
13,244
-43.0%
0.00%
Q2 2019$598,095,00023,2270.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders